LoginRegister
    Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque PsoriasisLilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque...
    Medical devices to be regulated as drugs for quality control, price monitoring: GovernmentMedical devices to be regulated as drugs for quality control, price monitoring: Government
    Novalead Pharma says 42 existing drugs can help in treating coronavirus patientsNovalead Pharma says 42 existing drugs can help in treating coronavirus patients
    Minister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSRMinister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSR
    US begins stockpiling malaria medicine for treating COVID-19 patientsUS begins stockpiling malaria medicine for treating COVID-19 patients
    Strides receives USFDA EIR for KRS Gardens, Bangalore facilityStrides receives USFDA EIR for KRS Gardens, Bangalore facility
    Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release CapsulesZydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules
    Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion VaccinesJohnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines
    AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysisAstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable...
    South Korean coronavirus test kit makers win USFDA pre-approvalSouth Korean coronavirus test kit makers win USFDA pre-approval
    Sanofi delays Slump Sale and transfer of Ankleshwar plantSanofi delays Slump Sale and transfer of Ankleshwar plant
    Lupin gets USFDA EIR for Inhalation Research Center, FloridaLupin gets USFDA EIR for Inhalation Research Center, Florida
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X